STAT3d
Potential competition for RSV prophylactic Beyfortus
New data released by Merck suggests AstraZeneca and Sanofi’s Beyfortus, the monoclonal antibody injection that protects ...
Alnylam Stock Up on Cardiomyopathy Drug Regulatory Filing in the EU
ALNY stock gains after submitting a regulatory application in the EU, seeking the approval of vutrisiran to treat ATTR ...
Alnylam Submits Regulatory Application to the European Medicines Agency for Vutrisiran for the Treatment of ATTR Amyloidosis with Cardiomyopathy
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNA interference (RNAi) therapeutics company, today announced the submission of a Type II Variation to the European Medicines Agency (EMA) for ...
Le Lézard5d
Mila Partners with Ability Biologics to Advance AI Innovations in Antibody Discovery
Ability Biologics ("Ability") is proud to announce a new partnership with Mila - Quebec Artificial Intelligence Institute. This partnership will bring together Mila's world-renowned network of experts ...
Alnylam Pharma Submits Type II Variation To European Medicines Agency For Vutrisiran
Alnylam Pharmaceuticals (ALNY) announced the submission of a Type II Variation to the European Medicines Agency for vutrisiran, an ...